Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes

Authors
Sattar, N Perera, M Small, M Lumsden, MA
Citation
N. Sattar et al., Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes, LANCET, 354(9177), 1999, pp. 487-488
Citations number
5
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
354
Issue
9177
Year of publication
1999
Pages
487 - 488
Database
ISI
SICI code
0140-6736(19990807)354:9177<487:HRTASC>2.0.ZU;2-D
Abstract
C-reactive protein concentrations as a marker of inflammation predicts vasc ular risk and is raised in type-2 diabetes. In a 6-month double-blind place bo controlled trial, a combination of transdermal oestradiol 80 mu g with c ontinuous oral norethisterone 1 mg significantly reduced C-reactive protein concentrations in postmenopausal women with type-2 diabetes.